Testing CBT Models and Change Mechanisms for Alcohol Dependent Women (WTPIII)

July 4, 2018 updated by: Elizabeth Epstein, Ph.D., Rutgers, The State University of New Jersey
The study has 4 specific aims: (1) To modify our existing Individual Female Specific Cognitive Behavioral Therapy (I-FS-CBT) for Alcohol Use Disorder (AUD) approach to treat women with alcohol dependence in a group format, Group Female Specific Cognitive Behavioral Therapy (G-FS-CBT); (2) To test the relative efficacy of I-FS-CBT and G-FS-CBT; (3) To test hypothesized mechanisms of change in drinking that are common to both treatments, including (a) coping skills and enhanced self-efficacy for abstinence; (b) enhanced sense of autonomy; (c) alleviation of negative affect, and (d) increased social network support for abstinence, and (4) To assess the relative cost-effectiveness of the individual and group treatment.

Study Overview

Status

Completed

Detailed Description

Participants completed a telephone screen for initial eligibility and were scheduled for an in-person clinical intake interview. Consented women were scheduled for a baseline research interview (BL) approximately one week later. At the end of the BL, participants were randomized to treatment condition. During the 12 session treatment period, women completed assessments at the beginning and end of each therapy session on secondary outcome and therapy process variables.

In I-FS-CBT each participant saw a therapist weekly. The first session was 90 minutes long, and subsequent sessions were 60 minutes long. The I-FS-CBT manual included core CBT, motivational enhancement, and relapse prevention components. Two core thematic women's issues were integrated into each session via discussion and illustrative material: (a) self-confidence and (b) self-care.

The G-FS-CBT manual included material identical to I-FS-CBT, but the session organization was modified for a closed group format. The group treatment was designed to provide didactic presentation of coping skills and motivational enhancement material, and group discussion and rehearsal of new skills within a supportive atmosphere that facilitated mutual emotional support and support for abstinence. The first session of G-FS-CBT was 2 hours; remaining sessions were 90 minutes.

In-person follow-up interviews were done at 3, 9, and 15 months post-session 1.

Study Type

Interventional

Enrollment (Actual)

155

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • age 18 or older
  • have a current (past year) Diagnostic and Statistical Manual-IV (DSM-IV) alcohol dependence diagnosis
  • used alcohol in the 60 days prior to telephone screening

Exclusion Criteria:

  • have psychotic symptoms in the past six months
  • gross cognitive impairment
  • current physiological dependence on any illicit drug

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: I-FS-CBT
In I-FS-CBT each participant saw a therapist weekly. The first session was 90 minutes long, and subsequent sessions were 60 minutes long. The I-FS-CBT manual included core CBT, motivational enhancement, and relapse prevention components. Two core thematic women's issues were integrated into each session via discussion and illustrative material: (a) self-confidence, and (b) self-care.
12 manual-guided sessions of I-FS-CBT
Experimental: G-FS-CBT
The G-FS-CBT manual included core CBT, motivational enhancement, and relapse prevention components. Two core thematic women's issues were integrated into each session via discussion and illustrative material: (a) self-confidence, and (b) self-care. The session organization was modified for a closed group format. The group treatment was designed to provide didactic presentation of coping skills and motivational enhancement material, and group discussion and rehearsal of new skills within a supportive atmosphere that facilitated mutual emotional support and support for abstinence.
12 manual-guided sessions of G-FS-CBT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent Drinking Days (PDD)
Time Frame: Change from baseline across 15 months post-session 1
Derived from Timeline Followback (TLFB)
Change from baseline across 15 months post-session 1
Percent Heavy Drinking Days (PHDD)
Time Frame: Change from baseline across 15 months post-session 1
Derived from TLFB; Defined as 4 or more standard drinks per day
Change from baseline across 15 months post-session 1
Mean Drinks Per Drinking Day (MDPDD)
Time Frame: Change from baseline across 15 months post-session 1
Derived from TLFB
Change from baseline across 15 months post-session 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Depression Inventory II
Time Frame: Baseline and through study completion, about 15 months
self-report questionnaire assessing depression symptoms over the prior two weeks (scores range 0-63) and higher scores indicate greater depression symptomatology. All item scores are summed to attain a total score.
Baseline and through study completion, about 15 months
Anxiety
Time Frame: Baseline and through study completion, about 15 months
Assessed anxiety symptoms in the last week (scores range 0-63) with higher scores indicating higher anxiety symptomatology. Item scores summed to attain total score.
Baseline and through study completion, about 15 months
Sociotropy-Autonomy Scale
Time Frame: Baseline and through study completion, about 15 months
Measures the extent of an individual's concern with others' opinion of herself (sociotropy) and self-confidence, behavioral and emotional independence (autonomy). Sociotropy sub scale ranges from 0 to 64 with higher scores indicating higher sociotropy. Average Sociotropy Scores are attained by averaging items, with total scores from 0 to 4. Autonomy sub scale Score range from 0 to 44 with higher scores indicating greater autonomy. Average Autonomy Scores are attained by averaging items, with total scores from 0 to 4.
Baseline and through study completion, about 15 months
Coping Strategies Scale
Time Frame: Baseline and through study completion, about 15 months
Assessed use frequency of 30 strategies to cope with alcohol use and non-alcohol related situations, on a scale of 1 (never) to 4 (frequently) for a mean score across all items
Baseline and through study completion, about 15 months
Situational Confidence Scale 8
Time Frame: Baseline and through study completion, about 15 months
Measured self-efficacy to abstain from alcohol use in high-risk situations; each item is rated 0% to 100% for a global confidence score.
Baseline and through study completion, about 15 months
Important People Inventory
Time Frame: Baseline and through study completion, about 15 months
Assessed social network structure, network drinking, and network response to drinking and abstinence. Percentage of network accepting/encouraging abstinence and percentage of network abstainers/in recovery were used.
Baseline and through study completion, about 15 months
Self care
Time Frame: Baseline and through study completion, about 15 months
Assessed 8 domains of self-care: seek medical care, have free time, pleasurable activities, social contact, attend treatment, exercise, do nice things for oneself, buy nice things for oneself
Baseline and through study completion, about 15 months
Inventory of Personal Problems
Time Frame: Baseline and through study completion, about 15 months
Assessed problems in 10 interpersonal domains, rated on a 0 to 4 scale. A total sum score was used for this study; higher scores reflect more interpersonal problems
Baseline and through study completion, about 15 months
Group Environment Scale Form R
Time Frame: Baseline and through study completion, about 15 months
Measured 10 group process subscales (e.g., Cohesiveness, Leader Support, Order/Organization, Expressiveness, Anger/Aggression), each with a mean scale score for 4 items rated on a 0-4 scale.
Baseline and through study completion, about 15 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
End of Treatment Questionnaire
Time Frame: 3 months post session 1
Measured client ratings of helpfulness of therapy elements on a 7 point scale of -3 (greatly harmful), -2, -1, 0 (neutral), +1, +2, +3 (greatly helpful).
3 months post session 1
Working Alliance Inventory - Short Form
Time Frame: Weekly during Treatment, about 15 weeks
12-item self-report measure of the therapeutic alliance (7-point scale with a total possible score of 84)
Weekly during Treatment, about 15 weeks
Therapy Integrity Rating Scale
Time Frame: Weekly during treatment, about 15 weeks
39 five-point Likert scale items to assess domains common to both treatment conditions (e.g., general interventions, female-specific interventions, common factors) and unique to a single treatment condition (e.g., group therapy interventions)
Weekly during treatment, about 15 weeks
Therapist Checklist
Time Frame: Weekly during Treatment, about 15 weeks
Coding treatment components delivered in each session from 3 to 0 as thoroughly, moderately, minimally, or not covered
Weekly during Treatment, about 15 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elizabeth E Epstein, PhD, Rutgers, The State University of New Jersey

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2010

Primary Completion (Actual)

April 28, 2014

Study Completion (Actual)

April 28, 2014

Study Registration Dates

First Submitted

June 8, 2018

First Submitted That Met QC Criteria

July 4, 2018

First Posted (Actual)

July 17, 2018

Study Record Updates

Last Update Posted (Actual)

July 17, 2018

Last Update Submitted That Met QC Criteria

July 4, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Use Disorder

Clinical Trials on I-FS-CBT

Subscribe